Nominations open for FDA Impact Award 2021

There is lots of fantastic work going on and our Impact Award is our way of recognising that work and saying thank you.
You can nominate a member, representative or branch who you think has made a difference in one (or more) of the following areas:
- Campaign: where a campaign has been run in a local area resulting in engaging members and/or a win on an issue.
- Engagement: members have been engaged to become more involved in the FDA, with high participation in branch structures/surveys or regular successful events.
- Branch development: introducing new forms of communication, recruiting members to the committee, increasing branch activity.
- Recruitment: where a large number of new members have been recruited, declining membership has been reversed, or where members have been recruited from unengaged areas or despite challenging circumstances.
- Casework: where a significant win has been achieved, a win on a difficult case or a win on a case that has resulted in wider change in the department.
- Negotiation: where a win has been achieved for members through negotiations with the employer.
To nominate an outstanding member, workplace rep or branch please complete this form and return by email to amy@fda.org.uk by midday Monday 12th April.
Related News
-
Prosecutors are undervalued, underpaid and overworked, says FDA responding to CJI NI report
The FDA has responded to a new report from the Criminal Justice Inspection Northern Ireland (CJI NI) into management and performance of the Public Prosecution Service (PPSNI).
-
FDA calls for pay parity on IfG panel discussing Fast Stream reform
FDA National Officer for the Fast Stream Robert Eagleton took part in the Institute for Government’s (IfG) panel event, ‘How can the Fast Stream deliver more for the civil service?’.
-
Lords Committee report highlights lack of evidence behind civil service 60% office working mandate
A new report from the House of Lords Select Committee on Home-Based Working, which features evidence from the FDA, says the government should lead by example with good hybrid working practices within the civil service.